Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Is Cognitive MS a Distinct Entity?
MS Research Roundup: April 8, 2014
Dronabinol
The Oligodendrocyte Whisperer
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
Gut Bacteria Boost Anti-Inflammatory Immune Cells in Mice
ONO-4641
Brain Atrophy, Early Antibody Spread in Pediatric MS
Time to Rethink CIS Criteria
Episode 92 with Dr. Shiv Saidha on using OCT to understand MS
Episode 88 with Dr. John Hart on electrical stimulation for cognition in MS
Episode 98 with Dr. David Baker on the use of animal models in medical research
159 Genetic Variants Now Known to Be Associated With MS
Vitamin D3 Blocks T Helper Cells From Entering the CNS
How should we refer to someone with MS?
The Power of Positive Thinking
Spinal Cord, Retinal Measures Independently Relate to MS Disability
Flupirtine
ISNVD 2016 Conference
GM-CSF: A Target for Brain Inflammation Intervention in MS?
Episode 90 with Dr. Daniel Hartung on pricing trends for MS disease-modifying therapies in the US
Transdermal Myelin Peptides May Be Safe, Effective in MS
Nature, Nurture, and What’s in Between
Naltrexone
Stopping Natalizumab May Increase Risk of MS Relapse

Pages

« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By